Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D Price Controls: House Bill Flags Issue As Health Reform Moves Ahead

This article was originally published in The Pink Sheet Daily

Executive Summary

A group of House Democrats is attempting to generate support for HHS drug price negotiations in Medicare Part D despite the fact that health care reform legislation is advancing without it.

You may also be interested in...



Government Drug Price Negotiations Still On President's Mind

At event on benefits of the Affordable Care Act, Obama indicates he still wants drug price negotiating power: "We can do a better job negotiating for better prices."

Government Drug Price Negotiations Still On President's Mind

At event on benefits of the Affordable Care Act, Obama indicates he still wants drug price negotiating power: "We can do a better job negotiating for better prices."

Obama Health Reform Plan Uses MA Cuts, Pharma Fees To Close Donut Hole

The Obama administration's proposal on health care reform would phase out the Medicare Part D coverage gap and pay for it through cuts to Medicare Advantage plans and with annual fees on branded biopharmaceutical companies

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS070452

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel